These results suggests that through inducing tumor cell ICD effect the miR-497/SK-NBs can enhance CD80+ CD86+ macrophage activation, which for more effective immune response against tumors in vivo, as compared with that associated with the SK-NBs or miR497-NBs. This evidence concerns the gene CD86 and neoplasm.